Efficacy and tolerability of antidepressants in people aged 65 years or older with major depressive disorder – A systematic review and a meta-analysis
Abstract
Background There has been a steady increase in the prescription of antidepressants for the elderly. This study comprises a systematic review of randomized, placebo-controlled trials of antidepressants for treatment of depressive disorder in people aged 65 years or more.Methods PubMed, EMBASE, Cochrane Library, CINAL, and PsycINFO were searched until May 2016. Where appropriate, the results were synthesized in meta-analyses.Results Twelve trials met the inclusion criteria. For patients with major depressive disorder, selective serotonin re-uptake inhibitors (SSRI) were not superior to placebo in achieving remission (OR: 0.79, 95% CI: 0.61-1.03) or response (OR=0.86, 95% CI: 0.51-1.10) after 8 weeks of treatment (three trials). However, maintenance treatment with SSRIs was superior to placebo in preventing relapse (OR: 0.22, 95% CI: 0.13-0.36; NNT=5, 95% CI: 3-6; two trials). Duloxetine was superior to placebo in achieving remission (OR: 1.78, 95% CI: 1.20-2.65; NNT=9, 95% CI: 6-20; three trials) and response (OR: 1.83, 95% CI: 1.96-4.08; two trials) in recurrent major depression after 8 weeks, but increased the risk of adverse events that can be problematic in the elderly.Limitations The quality of evidence was generally low or moderate, emphasizing the uncertainty of the results. Study populations only partly covered the heterogeneous population of elderly with depressed mood, limiting the generalizability.Conclusion The results underscore the importance of close monitoring of the effects of antidepressants in treatment of elderly patients with a depressive disorder. Methods for early detection of non-responders and effective treatment options for this group are needed.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Short-term use of low to moderate doses of antidepressants, particularly SSRIs, is generally well tolerated, including in older adults.
“Short-term use of low to moderate doses of antidepressants, and particularly of SSRIs, is generally well tolerated [14], and notably in older adults [15][16][17].”
From Association between antidepressant use and reduced risk of intubation or death in hospitalized patients with COVID-19: results from an observational study (2021) · cites this paper as [15]
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282 · see citing works
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962 · see citing works
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)
Hu, R. J. (2003) · Elsevier eBooks · doi:10.1016/b0-12-226870-9/01070-4 · Cited by 9,167 · see citing works
GRADE guidelines: 3. Rating the quality of evidence
Balshem, H., Helfand, M., Schünemann, H. J., Oxman, A. D., Kunz, R., Brozek, J., Vist, G. E., Falck-Ytter, Y., Meerpohl, J., & Norris, S. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.07.015 · Cited by 8,285 · see citing works
International Statistical Classification of Diseases and Related Health Problems
Eisfeld, J. (2014) · TSQ Transgender Studies Quarterly · doi:10.1215/23289252-2399740 · Cited by 3,570 · see citing works
Selective publication of antidepressant trials and its influence on apparent efficacy
Turner, E. H., Matthews, A. M., Linardatos, E., Tell, R. A., & Rosenthal, R. (2008) · New England Journal of Medicine · doi:10.1056/nejmsa065779 · Cited by 2,435 · see citing works
Luppa, M., Sikorski, C., Luck, T., Ehreke, L., Konnopka, A., Wiese, B., Weyerer, S., König, H.-H., & Riedel-Heller, S. G. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.11.033 · Cited by 855 · see citing works
Antidepressant use and risk of adverse outcomes in older people: population based cohort study
Coupland, C., Dhiman, P., Morriss, R., Arthur, A., Barton, G., & Hippisley-Cox, J. (2011) · BMJ · doi:10.1136/bmj.d4551 · Cited by 833 · see citing works
Overview of the Genetics of Major Depressive Disorder
Lohoff, F. W. (2010) · Current Psychiatry Reports · doi:10.1007/s11920-010-0150-6 · Cited by 498 · see citing works
Rovner, B. W. (1991) · JAMA · doi:10.1001/jama.265.8.993 · Cited by 495 · see citing works
Maintenance Treatment of Major Depression in Old Age
Reynolds, C. F., Dew, M. A., Pollock, B. G., Mulsant, B. H., Frank, E., Miller, M. D., Houck, P. R., Mazumdar, S., Butters, M. A., Stack, J. A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052619 · Cited by 476 · see citing works
Hamilton, M. (1980) · PubMed · Cited by 471 · see citing works
Heres, S., Davis, J. M., Maino, K., Jetzinger, E., Kissling, W., & Leucht, S. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.2.185 · Cited by 447 · see citing works
Katona, C., Hansen, T., & Olsen, C. K. (2012) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e3283542457 · Cited by 445 · see citing works
Rochon, P. A. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420020059007 · Cited by 353 · see citing works
Raskin, J., Wiltse, C. G., Siegal, A., Sheikh, J., Xu, J., Dinkel, J. J., Rotz, B. T., & Mohs, R. C. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.6.900 · Cited by 329 · see citing works
Antidepressants for depressed elderly
Mottram, P. G., Wilson, K., & Strobl, J. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003491.pub2 · Cited by 289 · see citing works
Lenze, E. J., Mulsant, B. H., Blumberger, D. M., Karp, J. F., Newcomer, J. W., Anderson, S. J., Dew, M. A., Butters, M. A., Stack, J. A., Begley, A. E., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00308-6 · Cited by 283 · see citing works
Tedeschini, E., Levkovitz, Y., Iovieno, N., Ameral, V. E., Nelson, J. C., & Papakostas, G. I. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10r06531 · Cited by 269 · see citing works
Prevalence of depressive symptoms and syndromes in later life in ten European countries
Costa, E., Dewey, M. E., Stewart, R. J., Banerjee, S., Huppert, F. A., de Mendonça-Lima, C. A., Büla, C., Reisches, F., Wancata, J., Ritchie, K. A., et al. (2007) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.107.036772 · Cited by 260 · see citing works
Nyth, A. L., Gottfries, C. G., Lyby, K., Smedegaard-Andersen, L., Jp, G.-S., Kristensen, M., Refsum, H. E., Øfsti, E., Eriksson, S., & Syversen, S. (1992) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1992.tb03242.x · Cited by 258 · see citing works
Copeland, J. R. M., Beekman, A. T. F., Dewey, M. E., Hooijer, C., Jordan, A., LAWLOR, B. A., Lobo, A., Magnússon, H., MANN, A. H., Meller, I., et al. (1999) · The British Journal of Psychiatry · doi:10.1192/bjp.174.4.312 · Cited by 240 · see citing works
Nelson, J. C., Delucchi, K., & Schneider, L. S. (2008) · The American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000308883.64832.ed · Cited by 230 · see citing works
Epidemiology of late-life mental disorders
Hybels, C. F., & Blazer, D. G. (2003) · Clinics in Geriatric Medicine · doi:10.1016/s0749-0690(03)00042-9 · Cited by 209 · see citing works
Depression as a major component of public health for older adults.
Chapman, D. P., & Perry, G. S. (2008) · PubMed Central · Cited by 206 · see citing works
Roose, S. P., Sackeïm, H. A., Krishnan, K., Pollock, B. G., Alexopoulos, G. S., Lavretsky, H., Katz, I. R., Hakkarainen, H., & Old-Old Depression Study Group (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.11.2050 · Cited by 189 · see citing works
Kok, R. M., Nolen, W. A., & Heeren, T. J. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.02.036 · Cited by 167 · see citing works
Response Inhibition Predicts Poor Antidepressant Treatment Response in Very Old Depressed Patients
Sneed, J. R., Roose, S. P., Keilp, J. G., Krishnan, K. R. R., Alexopoulos, G. S., & Sackeim, H. A. (2007) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3180302513 · Cited by 146 · see citing works
Schatzberg, A. F., & Roose, S. P. (2006) · American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000194645.70869.3b · Cited by 144 · see citing works
Gallo, J. J. (2005) · American Journal of Geriatric Psychiatry · doi:10.1176/appi.ajgp.13.9.748 · Cited by 127 · see citing works
Etkin, A., Patenaude, B., Song, Y. J. C., Usherwood, T., Rekshan, W. R., Schatzberg, A. F., Rush, A. J., & Williams, L. M. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.333 · Cited by 126 · see citing works
Escitalopram in the Treatment of Depressed Elderly Patients
Kasper, S. F. (2005) · American Journal of Geriatric Psychiatry · doi:10.1176/appi.ajgp.13.10.884 · Cited by 115 · see citing works
The Efficacy of Agomelatine in Elderly Patients With Recurrent Major Depressive Disorder
Heun, R., Ahokas, A., Boyer, P., Giménez-Montesinos, N., Pontes-Soares, F., Olivier, V., & Agomelatine Study Group (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12m08250 · Cited by 109 · see citing works
Klysner, R., Bent-Hansen, J., Hansen, H. L., Lunde, M., Pleidrup, E., Poulsen, D. L., Andersen, M., & Petersen, H. E. H. (2002) · The British Journal of Psychiatry · doi:10.1192/bjp.181.1.29 · Cited by 106 · see citing works
Escitalopram in the Treatment of Depressed Elderly Patients
Kasper, S. F., de Swart, H., & Andersen, H. F. (2005) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200510000-00008 · Cited by 99 · see citing works
Gallo, J. J., Bogner, H. R., Morales, K. H., Post, E. P., Have, T. T., & BRUCE, M. L. (2005) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200509000-00002 · Cited by 98 · see citing works
Change in Cognitive Functioning Following Acute Antidepressant Treatment in Late-Life Depression
Culang‐Reinlieb, M. E., Sneed, J. R., Keilp, J. G., Rutherford, B. R., Pelton, G. H., Devanand, D. P., & Roose, S. P. (2009) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181b4bf4a · Cited by 91 · see citing works
Escitalopram Prevents Relapse in Older Patients With Major Depressive Disorder
Gorwood, P. A. P. M., Weiller, E., Lemming, O. M., & Katona, C. (2007) · American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000240823.94522.4c · Cited by 87 · see citing works
Gebara, M. A., Lipsey, K. L., Karp, J. F., Nash, M. C., Iaboni, A., & Lenze, E. J. (2014) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2014.11.004 · Cited by 84 · see citing works
Sonnenberg, C., Deeg, D. J. H., Comijs, H. C., van Tilburg, W., & Beekman, A. T. F. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.03.009 · Cited by 81 · see citing works
Moderators of Outcome in Late-Life Depression: A Patient-Level Meta-Analysis
Nelson, J. C., Delucchi, K. L., & Schneider, L. S. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12070927 · Cited by 80 · see citing works
The Impact of Depression on Quality of Life of the Elderly
Gurland, B. J. (1992) · Clinics in Geriatric Medicine · doi:10.1016/s0749-0690(18)30488-9 · Cited by 77 · see citing works
Wilson, K. C. M., Mottram, P. G., Ashworth, L., & Abou-Saleh, M. T. (2003) · British Journal of Psychiatry · doi:10.1192/bjp.182.6.492 · Cited by 74 · see citing works
Depression and Its Correlates Among Older Adults Accessing Aging Services
Richardson, T. M., Friedman, B., Podgorski, C. A., Knox, K. L., Fisher, S. G., He, H., & Conwell, Y. (2011) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3182107e50 · Cited by 69 · see citing works
Stubbs, B., Stubbs, J. H., Gnanaraj, S. D., & Soundy, A. (2015) · International Psychogeriatrics · doi:10.1017/s104161021500126x · Cited by 69 · see citing works
Acute and Long-term Treatment of Late-Life Major Depressive Disorder: Duloxetine Versus Placebo
Robinson, M. J., Oakes, T. M. M., Raskin, J., Liu, P., Shoemaker, S., & Nelson, J. C. (2013) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2013.01.019 · Cited by 69 · see citing works
Wise, T. N., Wiltse, C. G., Iosifescu, D. V., Sheridan, M., Xu, J. Y., & Raskin, J. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01476.x · Cited by 62 · see citing works
Hewett, K., Chrzanowski, W., Jokinen, R., Felgentreff, R., Rk, S., Gee, M., Wightman, D., O'Leary, M., Millen, L., Leon, M., et al. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881108100254 · Cited by 54 · see citing works
Burrows, A. B., Salzman, C., Satlin, A., Noble, K., Pollock, B. G., & Gersh, T. (2002) · Depression and Anxiety · doi:10.1002/da.10014 · Cited by 51 · see citing works
Executive Functioning Complaints and Escitalopram Treatment Response in Late-Life Depression
Manning, K. J., Alexopoulos, G. S., Banerjee, S., Morimoto, S. S., Seirup, J. K., Klimstra, S. A., Yuen, G., Kanellopoulos, T., & Gunning-Dixon, F. (2015) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2013.11.005 · Cited by 49 · see citing works
Alcohol abuse: a source of reversible functional disability among residents of a VA nursing home
Oslin, D. W., Streim, J. E., Parmelee, P. A., Boyce, A. A., & Katz, I. R. (1997) · International Journal of Geriatric Psychiatry · doi:10.1002/(sici)1099-1166(199708)12:8 · Cited by 36 · see citing works
Wohlreich, M. M., Sullivan, M. D., Mallinckrodt, C. H., Chappell, A. S., Oakes, T. M. M., Watkin, J. G., & Raskin, J. (2009) · Psychosomatics · doi:10.1176/appi.psy.50.4.402 · Cited by 31 · see citing works
Natural history of pharmacotherapy of older depressed community residents
Wilson, K., Copeland, J. R. M., Taylor, S., & Donoghue, J. (1999) · The British Journal of Psychiatry · doi:10.1192/bjp.175.5.439 · Cited by 29 · see citing works
Depression and Reduced Bone Mineral Density at the Hip and Lumbar Spine
Stubbs, B., Brefka, S., Dallmeier, D., Stubbs, J. H., Vancampfort, D., & Denkinger, M. D. (2015) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000292 · Cited by 26 · see citing works
Stubbs, B. (2015) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2015.02.004 · Cited by 19 · see citing works
Brody, B. L., Field, L. C., Roch‐Levecq, A., Moutier, C. Y., Edland, S. D., & Brown, S. I. (2011) · Annals of Clinical Psychiatry · doi:10.1177/104012371102300407 · Cited by 9 · see citing works
Letter: Parkinson's disease worsened by nefazodone
Benazzi, F. (1997) · International Journal of Geriatric Psychiatry · doi:10.1002/(sici)1099-1166(199712)12:12 · Cited by 7 · see citing works
Flagged first, then by citations
3 of the 60 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Kleckner, I. R., Kamen, C. S., Gewandter, J. S., Mohile, N. A., Heckler, C. E., Culakova, E., Fung, C., Janelsins, M. C., Asare, M., Lin, P., et al. (2017) · Supportive Care in Cancer · doi:10.1007/s00520-017-4013-0 · Cited by 312 · see citing works
“However, duloxetine has not been shown to reduce numbness or completely eliminate CIPN pain [15], and it causes dry mouth, constipation, diarrhea, and dizziness [16].”
BackgroundHoertel, N., Sánchez-Rico, M., Vernet, R., Beeker, N., Jannot, A.-S., Neuraz, A., Salamanca, E., Paris, N., Daniel, C., Gramfort, A., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01021-4 · Cited by 269 · see citing works
Depression in Alzheimer’s Disease: Epidemiology, Mechanisms, and Treatment
Huang, Y.-Y., Gan, Y.-H., Yang, L., Cheng, W., & Yu, J.-T. (2024) · Biological Psychiatry · doi:10.1016/j.biopsych.2023.10.008 · Cited by 164 · see citing works
Potentially inadequate medications in the elderly: PRISCUS 2.0—first update of the PRISCUS list
Mann, N., Mathes, T., Sönnichsen, A. C., Pieper, D., Klager, E., Moussa, M., & Thürmann, P. (2023) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.m2022.0377 · Cited by 125 · see citing works
Monoamine oxidases in age-associated diseases: New perspectives for old enzymes
Santin, Y., Resta, J., Parini, A., & Mialet‐Perez, J. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101256 · Cited by 107 · see citing works
Management of Depression in Parkinson's Disease: A Systematic Review
STARKSTEIN, S. E., & Brockman, S. (2017) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12507 · Cited by 103 · see citing works
Jonsson, U., Bertilsson, G., Allard, P., Gyllensvärd, H., Söderlund, A., Tham, A., & Andersson, G. (2016) · PLOS ONE · doi:10.1371/journal.pone.0160859 · Cited by 87 · see citing works
“Many elderly patients have unsatisfactory responses to antidepressants [6], including problematic side effects and the risk of drug interactions.”
BackgroundSelf-citationChen, X.-D., Li, F., Zuo, H., & Zhu, F. (2025) · Depression and Anxiety · doi:10.1155/da/5553491 · Cited by 97 · see citing works
Silfvernagel, K., Westlinder, A., Andersson, S., Bergman, K., Diaz Hernandez, R., Fallhagen, L., Lundqvist, I., Masri, N., Viberg, L., Forsberg, M.-L., et al. (2018) · Cognitive Behaviour Therapy · doi:10.1080/16506073.2017.1388276 · Cited by 65 · see citing works
“These can be helpful, but they often cause more harm than psychological treatment alone, due to side effects and interactions between medications for other disorders and conditions (Tham et al., 2016).”
BackgroundSelf-citationExposure to Antidepressant Medication and the Risk of Incident Dementia
Kodesh, A., Sandin, S., Reichenberg, A., Rotstein, A., Pedersen, N. L., Ericsson, M., Karlsson, I., Davidson, M., & Levine, S. Z. (2019) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2019.05.019 · Cited by 62 · see citing works
Chen, Y., Li, X., Pan, B., Wang, B., Jing, G., Liu, Q., Li, Y., Bing, Z., Yang, K., Han, X., et al. (2019) · Aging & Mental Health · doi:10.1080/13607863.2019.1704219 · Cited by 53 · see citing works
Brännström, J., Lövheim, H., Gustafson, Y., & Nordström, P. (2019) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.3679 · Cited by 52 · see citing works
Baba, H., Kito, S., Nukariya, K., Takeshima, M., Fujise, N., Iga, J., Oshibuchi, H., Kawano, M., Kimura, M., Mizukami, K., et al. (2022) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13349 · Cited by 50 · see citing works
“However, in patients aged 65 years or older, some reports show no significant effects compared with placebo.(98,100) It is therefore important to fully assess the risks and benefits of antidepressant medication for elderly patients.”
BackgroundExpression of the PPM1F Gene Is Regulated by Stress and Associated with Anxiety and Depression
Wingo, A. P., Velasco, E. R., Florido, A., Lori, A., Choi, D. C., Jovanovic, T., Ressler, K. J., & Andero, R. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.08.013 · Cited by 44 · see citing works
“However, effectiveness of pharmacological treatments for anxiety and depressive disorders still remains rather limited with small effect sizes (3, 4).”
BackgroundAntidepressant pharmacotherapy in old-age depression—a review and clinical approach
Pruckner, N., & Holthoff‐Detto, V. (2017) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-017-2219-1 · Cited by 37 · see citing works
“Another important concern in treatment with SSRIs is the emergence of suicidal ideation and suicide attempts, which can increase within the first 2 months of treatment [33, 39].”
BackgroundResultInfluentialPalliative medicine and end-of-life care
Glover, T. L., & Kluger, B. M. (2019) · Handbook of clinical neurology · doi:10.1016/b978-0-12-804766-8.00030-3 · Cited by 32 · see citing works
Hoertel, N., Rico, M. S., Kornhuber, J., Gulbins, E., Reiersen, A. M., Lenze, E. J., Fritz, B. A., Jalali, F., Mills, E. J., Cougoule, C., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11195882 · Cited by 29 · see citing works
“Based on these results, fluoxetine, which is on the World Health Organization’s Model List of Essential Medicines, has the greatest in vitro inhibitory effect on the ASM-ceramide system [50], a favorable pharmacokinetic profile [66], and is one of the best in tolerability [8,9] among SSRIs, should be considered a prom…”
BackgroundResultAbusukhun, M., Winkler, M. S., Pöhlmann, S., Moerer, O., Meissner, K., Tampe, B., Hofmann-Winkler, H., Bauer, M. W., Gräler, M. H., & Claus, R. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.784989 · Cited by 24 · see citing works
“Notably in older adults, the short-term use of FIASMA is generally well tolerated (73, 74).”
BackgroundCannabis Use and Misuse in Older Adults
Khoury, R., Maliha, P., & Ibrahim, R. (2021) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2021.07.003 · Cited by 22 · see citing works
Cinalioglu, K., Lavín, P., Bein, M., Lesage, M., Gruber, J., Se, J., Bukhari, S. N., Sasi, N., Noble, H. R., Andree-Bruneau, M., et al. (2023) · Frontiers in Psychology · doi:10.3389/fpsyg.2023.1083219 · Cited by 22 · see citing works
“, 2020), and pharmacotherapy which can induce negative side effects, especially for older adults who are at a greater risk for adverse drug reactions (Tham et al., 2016).”
BackgroundGuu, T., Cassano, P., Li, W.-J., Tseng, Y.-H., Ho, W.-Y., Lin, Y., Lin, S.-Y., Chang, J. P., Mischoulon, D., & Su, K. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.12.065 · Cited by 21 · see citing works
Associations between psychological therapy outcomes for depression and incidence of dementia
John, A., Saunders, R., Desai, R., Bell, G., Fearn, C., Buckman, J. E. J., Brown, B., Nurock, S., Michael, S., Ware, P., et al. (2022) · Psychological Medicine · doi:10.1017/s0033291722002537 · Cited by 21 · see citing works
“It has been reported that older people are six times more likely to take medications for depression than their younger counterparts (Burns, 2015), though antidepressant use in older people has been associated with limited benefit and more adverse events (Mallery et al., 2019; Tham et al., 2016).”
BackgroundStoller, S., Capozza, S. J., Alberti, P., Lustberg, M. B., & Kleckner, I. R. (2023) · Supportive Care in Cancer · doi:10.1007/s00520-023-07734-2 · Cited by 27 · see citing works
“However, the usefulness of duloxetine for treating CIPN is limited by negative pharmacokinetic interactions [12, 13], poor uptake [14] and adherence, perhaps due to its side effects [15, 16], a prolonged time period of weeks to reach clinically effective dosage, and financial burden due to lack of insurance coverage.”
BackgroundSingh, N., Hazari, P. P., Mittal, P., Yadav, S. K., Kumar, N., Mishra, G., Dahiya, S., & Mishra, A. K. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177737 · Cited by 19 · see citing works
Peakman, G., Karunatilake, N., Seynaeve, M., Perera, G., Aarsland, D., Stewart, R. J., & Mueller, C. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-035147 · Cited by 20 · see citing works
Pei, L., Yi, Y., Guo, J., Chen, L., Zhou, J., Wu, X.-L., Sun, J., & Chen, H. (2022) · Acupuncture in Medicine · doi:10.1177/09645284221076512 · Cited by 21 · see citing works
Holper, L. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2019.11.012 · Cited by 20 · see citing works
Antidepressant use and stroke or mortality risk in the elderly
Ön, B. I., Vidal, X., Berger, U., Sabaté, M., Ballarín, E., Maisterra, O., San‐José, A., & Ibáñez, L. (2021) · European Journal of Neurology · doi:10.1111/ene.15137 · Cited by 19 · see citing works
Bojanić, I. (2024) · Depression and Anxiety · doi:10.1155/2024/5448587 · Cited by 18 · see citing works
Jonsson, U., Linton, S. J., Ybrandt, H., Ringborg, A., Leander, L., Moberg, K., Hultcrantz, M., & Arnberg, F. K. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.11.036 · Cited by 16 · see citing works
“Effects of both psychological and pharmacological treatments may differ between age groups (Cuijpers et al., 2020; Hetrick et al., 2021; Tham et al., 2016), underscoring the importance of age-specific adaptations and evaluations of interventions.”
BackgroundSelf-citationClinical pharmacological innovation in the treatment of depression
Witkin, J. M., Golani, L. K., & Smith, J. L. (2023) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2023.2198703 · Cited by 16 · see citing works
“effect size of clinical trials with SSRIs is often small, individual patients are greatly helped, and lives are saved [138,139].”
BackgroundDepression-Linked Beliefs in Older Adults with Depression.
Tanaka, K. (2019) · Journal of Clinical Nursing · doi:10.1111/jocn.15081 · Cited by 13 · see citing works
Yuan, Y., Lapane, K. L., Rothschild, A. J., & Ulbricht, C. M. (2020) · Aging & Mental Health · doi:10.1080/13607863.2020.1849021 · Cited by 14 · see citing works
Chan, H. C.-Y., & Lo, H. H. M. (2023) · Current Psychology · doi:10.1007/s12144-023-04536-x · Cited by 14 · see citing works
Antidepressants in the elderly.
Lindblad, A. J., Clarke, J., & Lu, S. (2019) · Europe PMC (PubMed Central) · Cited by 13 · see citing works
Hoertel, N., Rezaei, K., Rico, M. S., Delgado‐Álvarez, A., Kornhuber, J., Gulbins, E., Olfson, M., Vedrines, C. O., Carpinteiro, A., Cougoule, C., et al. (2023) · Pharmaceuticals · doi:10.3390/ph16081107 · Cited by 13 · see citing works
“ASM [52], is well-tolerated [53,54], and is in the World Health Organization’s Model List of Essential Medicines, this molecule should be prioritized for randomized clinical trials in patients with COVID-19 [29].”
BackgroundSiddiqui, F., Barbateskovic, M., Juul, S., Katakam, K. K., Munkholm, K., Gluud, C. N., & Jakobsen, J. C. (2021) · Systematic Reviews · doi:10.1186/s13643-021-01722-5 · Cited by 12 · see citing works
Kleckner, I. R., Park, S. B., Streckmann, F., Wiskemann, J., Hardy, S. J., & Mohile, N. A. (2021) · Springer eBooks · doi:10.1007/978-3-030-78663-2_8 · Cited by 12 · see citing works
MiR-182-5p: A Novel Biomarker in the Treatment of Depression in CSDS-Induced Mice
Zheng, Y.-B., Sheng, X.-M., Jin, X., & Guan, W. (2024) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyad064 · Cited by 10 · see citing works
“Depression in elderly people is a major public health concern, and many elderly patients have unsatisfactory responses to antidepressants (Tham et al., 2016), including problematic side effects and the risk of drug interactions.”
BackgroundDiscontinuation of Antidepressants in Older Adults: A Literature Review
Romdhani, A., Lehmann, S., & Schlatter, J. (2023) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s395449 · Cited by 10 · see citing works
“In general, studies have shown that the effectiveness and the tolerability of the AD in older adults depend on the pharmacologic class(16) and that early detection of “non-responders” is mandatory in order to adapt the treatment plan.(12) Table 2 Selection of Meta-Analyses of Primary Outcomes of Different Antidepressa…”
BackgroundYan, Z., Meng, F., He, M., & Li, Z. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1027994 · Cited by 10 · see citing works
“However, pharmacotherapy is associated with slow response to treatment, limited remission rate, and high risk of relapse (17).”
BackgroundUsefulness of mirtazapine and SSRIs in late-life depression: post hoc analysis of the GUNDAM study
Kato, M., Baba, H., Takekita, Y., Naito, M., Koshikawa, Y., Bandou, H., & Kinoshita, T. (2023) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-023-03563-8 · Cited by 10 · see citing works
“In a meta-analysis of eight RCTs in the elderly, a subgroup analysis of three duloxetine RCTs demonstrated efficacy of the antidepressant over placebo for acute depressive symptoms, whereas no significant benefit of antidepressants over placebo was observed in the overall analysis [7].”
ResultKleckner, I. R., Manuweera, T., Lin, P., Chung, K., Kleckner, A. S., Gewandter, J. S., Culakova, E., Tivarus, M. E., Dunne, R. F., Loh, K. P., et al. (2024) · Supportive Care in Cancer · doi:10.1007/s00520-024-08855-y · Cited by 11 · see citing works
“The drug duloxetine reduces pain in CIPN [4], but its side effects [7] and low uptake [8] suggest the need for more treatment options.”
Eimontas, J., Pakalniškienė, V., Biliūnaitė, I., & Andersson, G. (2021) · Trials · doi:10.1186/s13063-021-05903-4 · Cited by 10 · see citing works
“A meta-analysis revealed that treating depressed older adults with antidepressants had unsatisfactory results and frequently led to adverse events [9].”
BackgroundSelf-citationJelovac, A., Landau, S., Beeley, P., McCaffrey, C., Finnegan, M., Gusciute, G., Whooley, E., McDonogh, S., Thompson, S. E., Igoe, A., et al. (2025) · Psychological Medicine · doi:10.1017/s0033291725000807 · Cited by 10 · see citing works
“…2015), and considering the diminished efficacy and tolerability of conventional monoaminergic antidepressant treatments for late-life depression (Tham et al., 2016), our findings imply that ECT could be preferentially offered to older patients, especially those with psychotic features and…”
Generalizability of pharmacologic and psychotherapy trial results for late-life unipolar depression
Hoertel, N., Rotenberg, L., Schuster, J., Blanco, C., Lavaud, P., Hanon, C., Hozer, F., Teruel, E., Manetti, A., Costemale-Lacoste, J.-F., et al. (2019) · Aging & Mental Health · doi:10.1080/13607863.2019.1691146 · Cited by 10 · see citing works
van Essen, K., Akse, M., Pelgrim, T. C., Prick, A.-E. J. C., & Aalbers, S. (2025) · The Arts in Psychotherapy · doi:10.1016/j.aip.2025.102289 · Cited by 9 · see citing works
Potentially Inappropriate Drug Duplication in a Cohort of Older Adults with Dementia
Trenaman, S. C., Bowles, S. K., Kirkland, S., & Andrew, M. K. (2021) · Current Therapeutic Research · doi:10.1016/j.curtheres.2021.100644 · Cited by 8 · see citing works
Chemoreactomic analysis of citrulline malate molecules
Torshin, I. Y., Громова, О. А., Федотова, Л. Э., Gromov, A. N., & Владимирович, Р. К. (2017) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2017-2-30-35 · Cited by 7 · see citing works
Shang, W., Guo, L., Liu, Y. J., Li, Y., Qian, W., Guo, K., Yang, M., Wei, L. S., Xu, Z., Niu, J., et al. (2023) · Campbell Systematic Reviews · doi:10.1002/cl2.1354 · Cited by 6 · see citing works
The Effectiveness and Harms of Antidepressants
Morley, J. E. (2017) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2017.01.011 · Cited by 7 · see citing works
Antidepressants for major depression disorder in older people: a network meta-analysis
Robertson, L., Bertolini, F., Meader, N., Davies, S., Barbui, C., Gilbody, S. M., & Churchill, R. C. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013394 · Cited by 7 · see citing works
Dong, L., Xu, L., Li, Y., Lv, Y., Liu, H., Li, Y., Xu, F., Wu, J., Zheng, Q., & Li, L. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.12.103 · Cited by 7 · see citing works
Procter, N. G., Hamer, H. P., McGarry, D. E., Wilson, R. L., & Froggatt, T. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316718278 · Cited by 6 · see citing works
Rimmer, R. M., Costafreda, S. G., Mutz, J., Joseph, K., Brunoni, A. R., Loo, C. K. A., Padberg, F., Palm, U., & Fu, C. H. Y. (2022) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2022.100407 · Cited by 6 · see citing works
Neufeld, K. M., Mao, Y., West, C. L., Ahn, M., Hameed, H. A. A., Iwashita, E., Stanisz, A. M., Forsythe, P., Barbut, D., ZASLOFF, M. A., et al. (2024) · Communications Biology · doi:10.1038/s42003-023-05623-2 · Cited by 6 · see citing works
Menchón, J. M., Espadaler, J., Tuson, M., Sáiz‐Ruiz, J., Bobes, J., Vieta, E., Álvarez, E., & Pérez, V. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-018-1879-z · Cited by 6 · see citing works
Wang, Y.-H., Wang, Y.-L., Leung, D. K. Y., Ng, Z. L. Y., Chan, O. L. H., Wong, S. M. Y., Chan, R. C. L., Liu, T., Wong, G. H. Y., & Lum, T. Y. S. (2025) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-025-04781-6 · Cited by 5 · see citing works
L’utilisation des antidépresseurs dans l’épisode dépressif caractérisé unipolaire du sujet âgé
Péricaud, A., Straczek, C., Montastruc, F., Leboyer, M., Yrondi, A., & Arbus, C. (2022) · L Encéphale · doi:10.1016/j.encep.2021.11.006 · Cited by 5 · see citing works
Hvidberg, M. F. (2023) · Mental Health Science · doi:10.1002/mhs2.14 · Cited by 5 · see citing works
Selective serotonin reuptake inhibitor use, age-related neuropathology and cognition in late-life
Sood, A., Wilson, R. S., Yu, L., Wang, T., Schneider, J. A., Honer, W. G., & Bennett, D. A. (2023) · Psychiatry Research · doi:10.1016/j.psychres.2023.115471 · Cited by 5 · see citing works
Zhang, S., & Miao, C. (2025) · BMC Geriatrics · doi:10.1186/s12877-025-06626-w · Cited by 3 · see citing works
“…review and meta-analysis conducted by Tham et al. (2016) demonstrated that selective serotonin reuptake inhibitors (SSRIs), particularly escitalopram and sertraline, exhibited significant improvements in depressive symptoms and overall quality of life compared to placebo among older adults [24].”
Roy, J.-C., Rousseau, C., Jutel, A., Naudet, F., & Robert, G. (2022) · Systematic Reviews · doi:10.1186/s13643-022-01945-0 · Cited by 3 · see citing works
Depression in Indians 45 years and older: a roadblock in healthy ageing
Shidhaye, R. R. (2022) · The Lancet Psychiatry · doi:10.1016/s2215-0366(22)00233-4 · Cited by 3 · see citing works
Psychopharmacotherapy in Aged Patients
Štuhec, M., & Stoppe, G. (2020) · Springer eBooks · doi:10.1007/978-3-319-56015-1_269-1 · Cited by 3 · see citing works
Adverse Effects of Pharmacological Treatments of Major Depression in Older Adults
Sobieraj, D. M. (2019) · doi:10.23970/ahrqepccer215 · Cited by 3 · see citing works
Cheng, C.-M., Jeng, J., Chen, M.-H., Chang, W.-H., Liu, M.-N., Lin, W.-C., Tsai, S., Bai, Y.-M., Su, T.-P., & Li, C.-T. (2025) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.70111 · Cited by 3 · see citing works
“Older adults with depression also exhibit higher rates of pharmacological adverse events relative to younger patients, likely reflecting a greater burden of physical comorbidities and frequent polypharmacy [10–13].”
Liew, T. M., & Lee, C. S. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-019819 · Cited by 2 · see citing works
Ketamine treatment for depression in elderly inpatients: an observational case series
Römer, B., Maroni, S. S., Fevang, E., Helle, H. B., Stewart, L. H., Aarsland, D., & Vik‐Mo, A. O. (2025) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2025.100904 · Cited by 2 · see citing works
Drugs to Tune Up Glutamatergic Systems: Modulators of Glutamate Metabotropic Receptors
Sengmany, K., & Gregory, K. J. (2017) · Neuromethods · doi:10.1007/978-1-4939-7228-9_8 · Cited by 2 · see citing works
Shimizu, K., Yasuda, S., Maeshima, H., Ichikawa, T., & Baba, H. (2026) · Neuropsychopharmacology Reports · doi:10.1002/npr2.70109 · Cited by 1 · see citing works
“However, other meta-analyses involving patients aged ≥ 65 years showed no significant benefit by antidepressants [3, 4].”
Ciccone, C. D. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-60912-8.00006-3 · Cited by 1 · see citing works
Bein, M., Lesage, M., Dikaios, E., Chakravarty, M. M., Segal, Z. V., Royal, I., Speechley, M. R., Schiavetto, A., Blumberger, D. M., Sacchet, M. D., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.976636 · Cited by 1 · see citing works
“Furthermore, Antidepressants are discontinued in 30% of older adults due to tolerability issues (Tham et al., 2016; Lindblad et al., 2019).”
BackgroundVinarcsik, L., Smoller, C., & Grossberg, G. T. (2025) · Drugs & Aging · doi:10.1007/s40266-025-01221-5 · Cited by 1 · see citing works
Affektive Störungen und Erschöpfungssyndrome
Reuter, J., & Frey, M. (2018) · Elsevier eBooks · doi:10.1016/b978-3-437-15340-2.00006-9 · Cited by 1 · see citing works
Pitfalls in managing depression in older persons - electroconvulsive therapy retains a vital role?
Kitt, K., Fahy, S. T., Doherty, A. M., O’Keeffe, S. T., Murray, A., & Mulkerrin, E. C. (2020) · Journal of Gerontology and Geriatrics · doi:10.36150/2499-6564-400 · Cited by 1 · see citing works
Prescribed Psychotropic Drugs in the Elderly
Bourin, M. (2021) · Springer eBooks · doi:10.1007/978-3-030-61721-9_46 · Cited by 1 · see citing works
Antidepressants and the Risk of Dementia: Appropriate Consideration of Confounding by Indication
Kodesh, A., Sandin, S., Reichenberg, A., Rotstein, A., Pedersen, N. L., Ericsson, M., Karlsson, I., Davidson, M., & Levine, S. Z. (2019) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2019.12.004 · Cited by 1 · see citing works
Jacquet, B., Louchart, S., Obrecht, V., Putetto, M. P., Cohen, D., Furderer, C., Vincent, C., Polet, K., Hesse, S., & Pesce, A. (2020) · NPG. Neurologie, psychiatrie, gériatrie/NPG · doi:10.1016/j.npg.2020.08.006
Mental Health of Men in Later Life
Almeida, O. P. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108646765.024
Witkin, J. M., Golani, L. K., Cerne, R., Rahman, M. T., Li, G., Poe, M. M., Cook, J. M., & Smith, J. L. (2019) · OBM Geriatrics · doi:10.21926/obm.geriatr.1903073
El rol del placebo frente a los antidepresivos y aportes a la relación médico-paciente
Felipe León, C., Daniela Silva, E., & José Villagrán, L. (2021) · Revista chilena de neuro-psiquiatría · doi:10.4067/s0717-92272021000400334
Rolo, J., & von Humboldt, S. (2021) · Springer eBooks · doi:10.1007/978-3-030-22009-9_87
Price, M. (2022) · Springer eBooks · doi:10.1007/978-3-030-91975-7_26
Current Treatments for Depression
Krystal, J. H., & Charney, D. S. (2017) · Oxford University Press eBooks · doi:10.1093/med/9780190681425.003.0031
Rolo, J., & von Humboldt, S. (2019) · Springer eBooks · doi:10.1007/978-3-319-69892-2_87-1
Konsiliar- und Liaisondienste für psychische Störungen
Diefenbacher, A., Burian, R., & Härter, M. C. (2019) · Elsevier eBooks · doi:10.1016/b978-3-437-22485-0.00029-4
Psychopharmacotherapy in Aged Patients
Štuhec, M., & Stoppe, G. (2022) · Springer eBooks · doi:10.1007/978-3-030-62059-2_269
Depression and Care Strategies in Elderly People
Aylaz, R., & Yyldyz, E. (2018) · doi:10.19080/oajggm.2018.04.555628
“Major Depressive Disorder (MDD) is the most common psychiatric disorder in elderly patients, although the prevalence and severity of the sequelae are high, often the condition is unrecognized, untreated, or inadequately treated [21,22].”
BackgroundChallenges in the Therapy of Psychiatric Disorders in the Elderly
Stoppe, G., Bouckaert, F., Štuhec, M., & Hanon, C. (2024) · Cambridge University Press eBooks · doi:10.1017/9781009067287.012
Mufti, A. A., Mughal, H., Azeemi, M. U. H., Kamal, M. A., Rabbani, F., Mufti, K. A., Sultan, S. M., Ahmad, B. I., Nawaz, Z., Afridi, A., et al. (2023) · Journal of Pakistan Psychiatric Society · doi:10.63050/jpps.20.04.281
Redican, E., McDowell, R. D., Rosato, M., Murphy, J., & Leavey, G. (2024) · Aging & Mental Health · doi:10.1080/13607863.2024.2387667
“However, while some research indicates that antidepressants are effective in the treatment of depression in older adults (Hvidberg, 2023; Tham et al., 2016), their usage in later life carries certain risks including increased mortality rates, cardiovascular complications, fractures, falls,…”
Eficácia e segurança de diferentes classes de fármacos no tratamento da depressão
Martins, V. D., Jales, C. D. S., Maia, I. M. A., & Barbosa, L. M. (2024) · Contribuciones a las Ciencias Sociales · doi:10.55905/revconv.17n.8-402
Mehta, R., Falvey, J. R., Chen, C., Dong, Y., Shardell, M. D., Yamashita, T., & Orwig, D. (2024) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2024.11.001
Current Treatments for Depression
D, M. F. M., & Krystal, J. H. (2025) · Oxford University Press eBooks · doi:10.1093/med/9780197640654.003.0034
Ravenelle, R., Deng, S., Nelson, M., Pedersen, M. H., Mendez‐David, I., David, D. J. P., Luna, V. M., Turi, G. F., Abramson, M., Javitch, J. A., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.08.680712
Mean Differences and Standard Mean Difference: Important Differences in Quality of Life
Davis, M. P. (2025) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2025.11.021
Roy, J.-C., Rousseau, C., Jutel, A., Naudet, F., & Robert, G. (2022) · Figshare · doi:10.6084/m9.figshare.19607433
Siddiqui, F., Barbateskovic, M., Juul, S., Katakam, K. K., Munkholm, K., Gluud, C., & Jakobsen, J. C. (2021) · Figshare · doi:10.6084/m9.figshare.14759517
Siddiqui, F., Barbateskovic, M., Juul, S., Katakam, K. K., Munkholm, K., Gluud, C., & Jakobsen, J. C. (2021) · Figshare · doi:10.6084/m9.figshare.14759514
- Authors
- Tham, A., Jonsson, U., Andersson, G., Söderlund, A., Allard, P., & Bertilsson, G.
- Affiliations
- Karolinska Institutet (SE)
- Uppsala University (SE)
- Linköping University (SE)
- Mälardalen University (SE)
- SBU - Swedish Agency for Health Technology Assessment and Assessment of Social Services (SE)
- Corresponding author
- Bertilsson, Göran
- Venue
- Journal of Affective Disorders
- Publisher
- Elsevier BV
- Published
- 2016-11
- Volume
- 205
- Pages
- 1-12
- ISSN
- 0165-0327 (ISSN-L)
- OpenAlex
- W2434444698
- Cited by
- 104
- References
- 60
- Citations by year
- 2026: 4 · 2025: 12 · 2024: 8 · 2023: 14 · 2022: 15 · 2021: 15 · 2020: 6 · 2019: 14 · 2018: 6 · 2017: 9 · 2016: 1
- FWCI
- 1.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Affective Disorders (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Swedish Agency for Health Technology Assessment and Assessment of Social Services
- Topics
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Social Sciences › Psychology › Social Psychology › Mental Health Treatment and Access
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- antidepressants, major depressive disorder, older adults, selective serotonin reuptake inhibitors, duloxetine, remission, treatment response, relapse prevention, maintenance therapy, adverse events, tolerability, antidepressant efficacy
- MeSH terms
- Duloxetine Hydrochloride, Aged, Antidepressive Agents, Major Depressive Disorder, Humans, Odds Ratio, Treatment Outcome, Selective Serotonin Reuptake Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review